HSPG2 and bone cancer: Furthermore, Gq inhibitor YM 254890, PLC inhibitor U73122, IP3 inhibitor 2-APB, and AC inhibitor SQ22536 could attenuate TCI-induced chronic bone cancer pain (Figure 2G).